FDA Brief

Warning letters Drugs

FDA warning letter to

Bionateo Sp. z.o.o.

High riskIssued Nov 4, 2021Posted Nov 9, 2021Center for Drug Evaluation and Research | CDER

Bionateo, a Polish drugmaker, shipped hand sanitizer contaminated with methanol and isopropanol that FDA refused at the U.S. border.

What happened

FDA tested a batch of ALTAIO HAND SANITIZING GEL that was detained and refused admission when a U.S. importer tried to bring it in. The lab found methanol at 625 to 2,500 ppm, about 0.88% undeclared isopropanol, and less ethanol than the 80% stated on the label. There was no inspection; FDA instead held an April 22, 2021 teleconference with the firm and its U.S. agent and said the firm's later responses were incomplete.

What FDA found

  1. The hand sanitizer contained methanol, a toxic substance that is not allowed in these products, at levels up to 2,500 ppm, which shows the firm's quality assurance was not working as required.

    Section 501(a)(2)(B) of the FD&C Act (21 U.S.C. 351(a)(2)(B))
  2. The label said the product had 80% ethanol, but it actually had less, plus undeclared isopropanol and methanol, so the labeling is false or misleading.

    Section 502(a) of the FD&C Act (21 U.S.C. 352(a))
  3. The label did not list isopropyl alcohol or methyl alcohol (methanol) as ingredients.

    Section 502(e)(1)(A) of the FD&C Act (21 U.S.C. 352(e)(1)(A))
  4. The product is a new drug sold without FDA approval and does not meet the conditions for marketing without approval.

    Sections 505(a) and 301(d) of the FD&C Act (21 U.S.C. 355(a), 331(d))
  5. The label does not give a complete U.S. address or phone number where a serious adverse event could be reported.

    Section 502(x) of the FD&C Act (21 U.S.C. 352(x))
  6. The firm did not give FDA the requested assay results and the specific test methods it used for its ethanol ingredient and finished product.

    21 CFR 211.165

What FDA wants

FDA asks the firm to reply in writing within 15 working days with a full investigation of how methanol and isopropanol got into the product, a list of all raw materials and suppliers, batch records and a distribution reconciliation, and an independent assessment of its laboratory. FDA also strongly recommends hiring a qualified CGMP consultant before making drugs for the U.S. again.

Who should pay attention

  • brands and distributors that buy hand sanitizer from contract manufacturers
  • U.S. importers and registered agents of foreign drugmakers
  • retailers and pharmacies that stock hand sanitizer

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. World Perfumes Inc.

    World Perfumes failed to test drug ingredients for toxic contaminants and had inadequate water, FDA says.

    High risk
  2. RNA Bio/Pharma, Incorporated

    FDA found RNA Bio/Pharma failed to test homeopathic oral liquid drugs for dangerous contaminants and did not validate its water system.

    High risk
  3. Kabana Skin Care LLC

    Kabana Skin Care failed to test OTC drug ingredients and finished products, prompting a recall and halt of U.S. drug manufacturing.

    High risk
  4. Ningbo Riway Industrial Co., Ltd.

    Ningbo Riway Industrial, an OTC drug maker in China, was cited for manufacturing-practice failures and unapproved antiseptic wipes.

    High risk